TEMPE, Ariz.--(BUSINESS WIRE)--Sept. 22, 2005--Health Enhancement Products, Inc. today announced that it has filed a further patent application with the U.S. Patent and Trademark Office, relating to various methods of treatment using its phyto-percolate, ProAlgaZyme. This patent filing is directed to the treatment of a variety of diseases including cancer, cardiovascular disease, and diseases related to immune system deficient disorders. The patent filing is also directed to methods of treatment for weight loss, inflammatory disorders responsive to COX-2 inhibition and glucose control. The phyto-percolate is an enzyme complex derived from a specific combination of microorganisms including fresh water algae. As humans' age and chronic disease processes progress, a deficiency of the enzymes that carry out the body's waste detoxification and other processes may be experienced. A deficiency of enzymes can cause a chronic hyper-inflammatory state, and the disease process becomes much more complex. Without adequate enzymes in the body, the immune system and other metabolic processes become less efficient, making tissue repair slow and poorly replicated.

The patent application is for a method of treating or preventing a disease or disorder in a human by ingesting a phyto-percolate, which is derived from mixtures including freshwater algae, in this case being ProAlgaZyme. There are several treatment aspects of this patent application, which are supported by clinical data, including methods of treating immune system deficiency, type I and II diabetes, diseases related to the heart, Cancer, Arthritis, and most other diseases related to a deficient immune system. The patent application is also directed to methods of weight control using ProAlgaZyme.

Michael Tempesta, President of Health Enhancement Products, Inc., said, "Based on the preliminary results we have had with our various studies involving ProAlgaZyme, filing for this further patent was important to protect methods of treatment using the product. We are in discussion with several large distributors who have expressed an interest in the sale and distribution of ProAlgaZyme initially as a weight loss product, and consequently we need to protect these important method-of-treatment claims."

About Health Enhancement Products, Inc.

Health Enhancement Products, Inc. (OTC: HEPI - News ) is a nutraceutical company engaged in the development of supplementary health-enhancing products using only pure, all-natural ingredients.

The company's sole product is ProAlgaZyme, a water that is produced from algae and other microorganisms grown in 100% distilled water. Recent studies performed by the company have indicated that ProAlgaZyme supports a compromised immune system.

Except for any historical information, the matters discussed in this press release contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements involve risks and uncertainties. A number of factors could cause actual results to differ from those indicated in the forward-looking statements, including the company's ability to fund its operations and market and sell its ProAlgaZyme product. Such statements are subject to a number of assumptions, risks and uncertainties. Readers are cautioned that such statements are not guarantees of future performance and that actual results or developments may differ materially from those set forth in the forward-looking statements. The company undertakes no obligation to publicly update or revise forward-looking statements, whether as a result of new information or otherwise.

Contact:

Health Enhancement Products, Inc.
Howard R. Baer,
480-385-3800